H10: manufacturing review: based on the information available it is not reasonably suggested that a manufacturing process may have caused or contributed to the reported issue.However, the lot history records of this lot were reviewed with special attention to the manufacturing and inspection of this product and the product was found to have met the specification prior to shipment.Investigation summary: a physical sample was returned for evaluation.The t-luer adapter was found detached from the slider which made a successful deployment using the trigger impossible.The stent was still loaded in the delivery catheter and could be deployed during deployment test using the conventional method at normal deployment forces.It was reported that a 0.035" guidewire was used, there was no tortuosity, and pre-dilatation was performed.The failure to deploy using the trigger is considered to have resulted from the detachment of the t-luer adapter from the slider.Based on available information and evaluation of the returned sample, the investigation was closed with confirmed results for detachment and the subsequent failure to deploy using the trigger is considered as a cascading event.A definite root cause for the reported event could not be determined.The intended placement of the device in the iliac vein represents an off-label use.Labeling review: in reviewing the relevant labeling it was found that the instructions for use sufficiently address the potential risks.With regards to device warnings, the instructions for use states "should unusual resistance be felt at any time during the procedure, the entire system (introducer sheath or guiding catheter and stent delivery system) should be removed as a single unit".Regarding accessories, the instructions for use states "the bard s.A.F.E.6f delivery system requires a minimum 8f guiding catheter, or a minimum 6f introducer sheath.Via the femoral route, insert a 0.035 inch (0.89 mm) guidewire under fluoroscopic guidance through the appropriate introducer sheath or guiding catheter and pass the lesion".With regards to indications for use, the instructions for use states "the e-luminexx vascular stent is indicated for the treatment of atherosclerotic lesions in the common and external iliac artery".H10: d4 (expiration date: 04/2026).H11: section a through f ¿ the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.H3 other text : see h10.
|
It was reported that during a stent placement procedure in iliac vein through femoral artery approach, the stent allegedly could not be opened and released.It was further reported that the release handle was allegedly little loose.There was no reported patient injury,.
|